Gene_NN expression_NN profile_NN of_IN HIV-1_NP Tat_NP expressing_VBG cells_NNS :_: a_DT close_JJ interplay_NN between_IN proliferative_JJ and_CC differentiation_NN signals_NNS Abstract_NP |_SYM Background_NP |_SYM Expression_NN profiling_VBG holds_VBZ great_JJ promise_NN for_IN rapid_JJ host_NN genome_NN functional_JJ analysis_NN ._SENT It_PP is_VBZ plausible_JJ that_IN host_NN expression_NN profiling_VBG in_IN an_DT infection_NN could_MD serve_VB as_IN a_DT universal_JJ phenotype_NN in_IN virally_RB infected_JJ cells_NNS ._SENT Here_RB ,_, we_PP describe_VBP the_DT effect_NN of_IN one_CD of_IN the_DT most_RBS critical_JJ viral_JJ activators_NNS ,_, Tat_NP ,_, in_IN HIV-1_JJ infected_JJ and_CC Tat_NP expressing_VBG cells_NNS ._SENT We_PP utilized_VBD microarray_NN analysis_NN from_IN uninfected_JJ ,_, latently_RB HIV-1_JJ infected_JJ cells_NNS ,_, as_RB well_RB as_IN cells_NNS that_WDT express_VBP Tat_NP ,_, to_TO decipher_VB some_DT of_IN the_DT cellular_JJ changes_NNS associated_VBN with_IN this_DT viral_JJ activator_NN ._SENT Results_NNS |_SYM Utilizing_JJ uninfected_JJ ,_, HIV-1_JJ latently_RB infected_JJ cells_NNS ,_, and_CC Tat_NP expressing_VBG cells_NNS ,_, we_PP observed_VBD that_IN most_JJS of_IN the_DT cellular_JJ host_NN genes_NNS in_IN Tat_NP expressing_VBG cells_NNS were_VBD down-regulated_JJ ._SENT The_DT down-regulation_NN in_IN Tat_NP expressing_VBG cells_NNS is_VBZ most_RBS apparent_JJ on_IN cellular_JJ receptors_NNS that_WDT have_VBP intrinsic_JJ receptor_NN tyrosine_NN kinase_NN (_( RTK_NP )_) activity_NN and_CC signal_VB transduction_NN members_NNS that_WDT mediate_VBP RTK_NP function_NN ,_, including_VBG Ras-Raf-MEK_NP pathway_NN ._SENT Co-activators_NNS of_IN transcription_NN ,_, such_JJ as_IN p300/CBP_NP and_CC SRC-1_NP ,_, which_WDT mediate_VBP gene_NN expression_NN related_VBN to_TO hormone_NN receptor_NN genes_NNS ,_, were_VBD also_RB found_VBN to_TO be_VB down-regulated_JJ ._SENT Down-regulation_NN of_IN receptors_NNS may_MD allow_VB latent_JJ HIV-1_JJ infected_JJ cells_NNS to_TO either_RB hide_VB from_IN the_DT immune_JJ system_NN or_CC avoid_VB extracellular_JJ differentiation_NN signals_NNS ._SENT Some_DT of_IN the_DT genes_NNS that_WDT were_VBD up-regulated_VBN included_VBN co-receptors_NNS for_IN HIV-1_JJ entry_NN ,_, translation_NN machinery_NN ,_, and_CC cell_NN cycle_NN regulatory_JJ proteins_NNS ._SENT Conclusions_NNS |_SYM We_PP have_VBP demonstrated_VBN ,_, through_IN a_DT microarray_NN approach_NN ,_, that_WDT HIV-1_NP Tat_NP is_VBZ able_JJ to_TO regulate_VB many_JJ cellular_JJ genes_NNS that_WDT are_VBP involved_VBN in_IN cell_NN signaling_VBG ,_, translation_NN and_CC ultimately_RB control_VB the_DT host_NN proliferative_JJ and_CC differentiation_NN signals_NNS ._SENT Whole-genome_NN expression_NN profiling_VBG exemplified_VBN by_IN the_DT development_NN of_IN DNA_NN microarrays_NNS represents_VBZ a_DT major_JJ advance_NN in_IN genome-wide_JJ functional_JJ analysis_NN ._SENT In_IN a_DT single_JJ assay_NN ,_, the_DT transcriptional_JJ response_NN of_IN each_DT gene_NN to_TO a_DT change_NN in_IN cellular_JJ state_NN can_MD be_VB measured_VBN ,_, whether_IN it_PP is_VBZ a_DT viral_JJ infection_NN ,_, host_NN cell_NN cycle_NN changes_NNS ,_, chemical_JJ treatment_NN ,_, or_CC genetic_JJ perturbation_NN ._SENT Specifically_RB ,_, systematic_JJ approaches_NNS for_IN identifying_VBG the_DT biological_JJ functions_NNS of_IN cellular_JJ genes_NNS altered_VBN during_IN these_DT changes_NNS ,_, such_JJ as_IN HIV-1_JJ infection_NN ,_, are_VBP needed_VBN to_TO ensure_VB rapid_JJ progress_NN in_IN defining_VBG significant_JJ host_NN and_CC viral_JJ genome_NN sequences_NNS in_IN directed_VBN experimentation_NN and_CC applications_NNS ._SENT Therefore_RB ,_, host_VB cellular_JJ states_NNS can_MD be_VB inferred_VBN from_IN the_DT expression_NN profiles_NNS ,_, and_CC the_DT notion_NN that_IN the_DT global_JJ transcriptional_JJ response_NN constitutes_VBZ a_DT detailed_JJ molecular_JJ phenotype_NN ,_, such_JJ as_IN class_NN discovery_NN ,_, class_NN prediction_NN ,_, drug_NN target_NN validation_NN ,_, and_CC the_DT classification_NN of_IN tumors_NNS by_IN expression_NN profiling_VBG has_VBZ begun_VBN to_TO receive_VB considerable_JJ attention_NN ._SENT Since_IN its_PP$ discovery_NN ,_, much_RB of_IN the_DT mainstream_JJ human_JJ immunodeficiency_NN virus_NN type_NN 1_CD (_( HIV-1_NP )_) Tat_NP research_NN has_VBZ focused_VBN on_IN its_PP$ ability_NN to_TO activate_VB the_DT HIV-1_NP LTR_NP ._SENT However_RB ,_, to_TO date_VB ,_, besides_IN the_DT transactivation_NN activity_NN on_IN the_DT HIV-1_JJ promoter_NN ,_, few_JJ other_JJ effects_NNS exerted_VBN by_IN HIV-1_NP Tat_NP on_IN cellular_JJ and_CC viral_JJ genes_NNS has_VBZ also_RB been_VBN observed_VBN ._SENT The_DT Tat_NP protein_NN has_VBZ been_VBN shown_VBN to_TO transcriptionally_RB repress_VB host_NN cellular_JJ genes_NNS and_CC be_VB involved_VBN in_IN the_DT immunosuppression_NN associated_VBN with_IN viral_JJ infection_NN ._SENT For_IN instance_NN ,_, HIV-1_JJ infection_NN is_VBZ able_JJ to_TO down-regulate_VB major_JJ histocompatibility_NN complex_JJ type_NN I_PP (_( MHC-I_NP )_) by_IN various_JJ different_JJ viral_JJ proteins_NNS ,_, including_VBG Tat_NP which_WDT represses_VBZ the_DT transcription_NN of_IN MHC-I_NP ,_, Vpu_NP which_WDT retains_VBZ nascent_JJ MHC-I_NP chains_NNS in_IN the_DT endoplasmic_JJ reticulum_NN ,_, and_CC Nef_NP which_WDT can_MD mediate_VB selective_JJ internalization_NN of_IN MHC-I_NP molecules_NNS from_IN the_DT plasma_NN membrane_NN ._SENT MHC_NP class_NN I_NP gene_NN expression_NN has_VBZ also_RB been_VBN shown_VBN to_TO be_VB reduced_VBN upon_IN infection_NN with_IN the_DT wild-type_JJ LAI_NP virus_NN or_CC a_DT Tat_NP exon_NN one_CD recombinant_JJ virus_NN ._SENT Tat_NP has_VBZ been_VBN shown_VBN to_TO down-regulate_VB mannose_NN receptor_NN ,_, EDF-1_NP ,_, CD3-gamma_NP ,_, and_CC TCR/CD3_NP surface_NN receptor_NN ._SENT Tat_NP reduces_VBZ mannose_NN receptor_NN levels_NNS and_CC promoter_NN activity_NN in_IN mature_JJ macrophages_NNS and_CC dendritic_JJ cells_NNS by_IN interfering_VBG with_IN the_DT host_NN transcriptional_JJ machinery_NN ;_: resulting_VBG in_IN decreased_VBN levels_NNS of_IN surface_NN mannose_NN receptor_NN needed_VBN for_IN Ag_NP (_( mannosylated_JJ albumin_NN uptake_NN )_) or_CC pathogen_NN capture_NN (_( Pneumocystis_NP carinii_NP phagocytosis_NN )_) ,_, and_CC eventual_JJ delivery_NN to_TO MHC_NP class_NN II-containing_NP intracellular_JJ compartments_NNS ._SENT EDF-1_NP ,_, a_DT gene_NN down-regulated_VBD when_WRB endothelial_JJ cells_NNS are_VBP induced_VBN to_TO differentiate_VB in_IN vitro_NN ,_, was_VBD shown_VBN to_TO be_VB down-regulated_VBN by_IN Tat_NP at_IN the_DT transcriptional_JJ level_NN ,_, resulting_VBG in_IN the_DT inhibition_NN of_IN endothelial_JJ cell_NN growth_NN and_CC in_IN the_DT transition_NN from_IN a_DT nonpolar_JJ cobblestone_NN phenotype_NN to_TO a_DT polar_JJ fibroblast-like_JJ phenotype_NN ._SENT When_WRB examining_VBG the_DT in_IN vivo_JJ effects_NNS of_IN HIV-1_NP Tat_NP protein_NN in_IN the_DT Xenopus_NP embryo_NN ,_, it_PP was_VBD found_VBN that_IN upon_IN injection_NN of_IN synthetic_JJ Tat_NP mRNA_NN into_IN zygotes_NNS ,_, a_DT marked_JJ delay_NN in_IN gastrulation_NN occurred_VBD ._SENT This_DT led_VBD to_TO the_DT altered_JJ specification_NN of_IN the_DT anterior-posterior_NN axis_NN and_CC partial_JJ loss_NN of_IN the_DT anterior_JJ embryo_NN structures_NNS ._SENT Mechanistically_RB ,_, HIV-1_NP Tat_NP elicited_VBD a_DT general_JJ suppression_NN of_IN gene_NN expression_NN ,_, including_VBG that_IN of_IN Xbra_NP and_CC gsc_NP ,_, two_CD early_JJ genes_NNS whose_WP$ expression_NN are_VBP required_VBN for_IN proper_JJ gastrulation_NN ._SENT In_IN relation_NN to_TO the_DT cell_NN cycle_NN ,_, Tat_NP has_VBZ also_RB been_VBN shown_VBN to_TO bind_VB to_TO p53_NN and_CC inhibit_VB the_DT transcription_NN of_IN p53_CD responsive_JJ elements_NNS ,_, such_JJ as_IN the_DT p21/Waf1_JJ gene_NN promoter_NN ._SENT Consequently_RB ,_, upon_IN introduction_NN of_IN stress_NN signals_NNS (_( e.g._FW ,_, gamma_NN irradiation_NN )_) ,_, HIV-1-infected_NP cells_NNS lose_VBP their_PP$ G1/S_NP checkpoint_NN ,_, enter_VBP the_DT S-phase_NN inappropriately_RB ,_, and_CC apoptose_NN ._SENT Finally_RB ,_, the_DT inhibition_NN of_IN Tat_NP on_IN translational_JJ machinery_NN has_VBZ also_RB been_VBN noted_VBN ._SENT The_DT potential_JJ translational_JJ inhibitory_JJ effects_NNS of_IN the_DT TAR_NP RNA_NP region_NN is_VBZ mediated_VBN by_IN the_DT activation_NN of_IN p68_NN (_( the_DT interferon-induced_JJ 68-kilodalton_JJ protein_NN kinase_NN )_) kinase_NN ,_, which_WDT was_VBD down-regulated_VBN by_IN Tat_NP during_IN productive_JJ HIV-1_JJ infection_NN ._SENT Although_IN the_DT mechanism_NN of_IN the_DT host_NN cellular_JJ down-regulation_NN remains_VBZ largely_RB unknown_JJ ,_, few_JJ reports_NNS have_VBP attempted_VBN to_TO decipher_VB the_DT mechanism_NN of_IN the_DT observed_JJ inhibition_NN ._SENT For_IN instance_NN ,_, the_DT addition_NN of_IN Tat_NP to_TO PC12_NP cells_NNS up-regulated_VBD the_DT expression_NN of_IN the_DT inducible_JJ cAMP_NN early_JJ repressor_NN (_( ICER_NP )_) ,_, a_DT specific_JJ member_NN of_IN the_DT cAMP-responsive_JJ element_NN modulator_NN transcription_NN factor_NN family_NN ,_, in_IN a_DT cAMP-dependent_JJ manner_NN ._SENT In_IN turn_NN ,_, ICER_NP overexpression_NN abrogated_VBD the_DT transcriptional_JJ activity_NN of_IN the_DT TH_JJ promoter_NN ,_, strongly_RB suggesting_VBG ICER_NP 's_POS involvement_NN in_IN Tat-mediated_JJ inhibition_NN of_IN gene_NN expression_NN ._SENT Aside_RB from_IN induction_NN of_IN ICER_NP ,_, Tat_NP is_VBZ capable_JJ of_IN forming_VBG complex_JJ (_( es_NP )_) with_IN a_DT component_NN of_IN TFIID_NP ,_, TAFII250_NP and_CC Tip60_NP both_CC of_IN which_WDT contain_VBP histone_NN acetyltransferase_NN (_( HAT_NP )_) activity_NN ._SENT In_IN these_DT cases_NNS ,_, Tat-TAFII250_NP and_CC Tat-Tip60_NP do_VBP not_RB affect_VB the_DT transcription_NN from_IN the_DT HIV-1_NP LTR_NP ,_, but_CC interfere_VB with_IN the_DT transcription_NN activity_NN of_IN cellular_JJ genes_NNS ._SENT It_PP is_VBZ postulated_VBN that_IN different_JJ targets_NNS of_IN HATs_NP by_IN Tat_NP have_VBP different_JJ consequences_NNS ._SENT The_DT interaction_NN of_IN Tat_NP with_IN p300/CBP_NP and_CC P/CAF_NP stimulates_VBZ its_PP$ ability_NN to_TO transactivate_JJ LTR-dependent_NP transcription_NN ,_, while_IN Tat-TAFII250_NP or_CC Tat-Tip60_NP interactions_NNS control_VBP the_DT transcription_NN of_IN cellular_JJ genes_NNS ._SENT Here_RB to_TO better_RBR understand_VB the_DT host_NN response_NN to_TO Tat_NP ,_, we_PP have_VBP performed_VBN microarray_NN experiments_NNS on_IN HIV-1_JJ infected_JJ cells_NNS expressing_VBG the_DT Tat_NP protein_NN ._SENT To_TO our_PP$ surprise_JJ many_JJ host_NN cellular_JJ genes_NNS were_VBD down-regulated_JJ when_WRB comparing_VBG HIV-1_JJ infected_JJ latent_JJ cells_NNS to_TO uninfected_JJ parental_JJ cells_NNS ._SENT Because_IN most_JJS ,_, if_IN not_RB all_RB ,_, latent_JJ infected_JJ cells_NNS available_JJ to_TO date_VB (_( e.g._FW ,_, ACH2_NP ,_, U1_NP ,_, J1.1_NP ,_, OM.10_NP )_) have_VBP various_JJ expression_NN levels_NNS of_IN doubly_RB spliced_VBN viral_JJ mRNAs_NNS ,_, including_VBG Tat_NP ,_, Rev_NP ,_, Nef_NP ,_, Vpr_NP ,_, and_CC other_JJ accessory_JJ proteins_NNS ,_, we_PP decided_VBD to_TO perform_VB the_DT microarray_NN in_IN a_DT system_NN where_WRB Tat_NP was_VBD constitutively_RB expressed_VBN ;_: asking_VBG whether_IN Tat_NP by_IN itself_PP ,_, or_CC in_IN the_DT absence_NN of_IN other_JJ accessory_JJ proteins_NNS ,_, could_MD still_RB down-regulate_VB host_NN cellular_JJ genes_NNS ._SENT Consistent_JJ with_IN latently_RB infected_JJ cells_NNS ,_, we_PP found_VBD many_JJ cellular_JJ genes_NNS to_TO be_VB down-regulated_VBN in_IN Tat_NP expressing_VBG lymphocytes_NNS ._SENT The_DT down-regulation_NN is_VBZ most_RBS apparent_JJ on_IN cellular_JJ receptors_NNS that_WDT have_VBP intrinsic_JJ receptor_NN tyrosine_NN kinase_NN (_( RTK_NP )_) activity_NN and_CC signal_VB transduction_NN members_NNS that_WDT mediate_VBP RTK_NP function_NN ;_: including_VBG the_DT Ras-Raf-MEK_NP pathway_NN ,_, and_CC co-activators_NNS such_JJ as_IN p300/CBP_NP and_CC SRC-1_NP ,_, which_WDT mediate_VBP gene_NN expression_NN related_VBN to_TO hormone_NN receptor_NN genes_NNS ._SENT Interestingly_RB ,_, we_PP also_RB observed_VBD up-regulation_NN of_IN S-phase_NP genes_NNS ,_, as_RB well_RB as_IN ribosomal_JJ genes_NNS involved_VBN in_IN translation_NN ._SENT Functionally_RB ,_, down-regulation_NN of_IN receptors_NNS may_MD allow_VB latent_JJ HIV-1_JJ infected_JJ cells_NNS to_TO either_RB hide_VB from_IN the_DT immune_JJ system_NN or_CC avoid_VB extracellular_JJ differentiation_NN signals_NNS normally_RB regulated_VBN by_IN receptors_NNS ._SENT Up-regulation_NN of_IN S-phase_NN and_CC translation_NN genes_NNS may_MD allow_VB speeding_VBG of_IN cells_NNS through_IN the_DT S-phase_NP and_CC subsequent_JJ accumulation_NN at_IN the_DT G2_NP phase_NN ,_, where_WRB most_JJS of_IN the_DT cellular_JJ and_CC viral_JJ translation_NN may_MD take_VB place_NN ._SENT Therefore_RB ,_, the_DT presence_NN of_IN Tat_NP may_MD not_RB only_RB control_VB activated_VBN transcription_NN on_IN HIV-1_NP LTR_NP ,_, but_CC also_RB aid_NN in_IN the_DT subsequent_JJ translation_NN of_IN viral_JJ mRNA_NN in_IN the_DT cytoplasm_NN ._SENT Host_NN expression_NN profiling_VBG in_IN a_DT sufficiently_RB large_JJ and_CC diverse_JJ set_NN of_IN profiles_NNS could_MD allow_VB additional_JJ hypotheses_NNS to_TO be_VB drawn_VBN regarding_VBG the_DT function_NN of_IN genes_NNS based_VBN on_IN the_DT regulatory_JJ characteristics_NNS of_IN their_PP$ own_JJ transcripts_NNS ._SENT Here_RB ,_, we_PP describe_VBP the_DT effect_NN of_IN one_CD of_IN the_DT most_RBS critical_JJ viral_JJ activators_NNS ,_, Tat_NP ,_, involved_VBN in_IN HIV-1_JJ infection_NN and_CC pathogenesis_NN ._SENT The_DT rationale_NN for_IN these_DT experiments_NNS came_VBD from_IN the_DT fact_NN that_IN many_JJ AIDS-infected_JJ patients_NNS who_WP are_VBP either_RB at_IN stage_NN III_NP (_( non-progressors_NP )_) or_CC under_IN highly_RB active_JJ antiretroviral_JJ therapy_NN (_( HAART_NP )_) treatment_NN show_VBP some_DT level_NN of_IN doubly_RB spliced_VBN viral_JJ messages_NNS in_IN their_PP$ infected_JJ cells_NNS ._SENT One_CD of_IN these_DT messages_NNS ,_, Tat_NP ,_, has_VBZ been_VBN well_RB studied_VBN and_CC characterized_VBN ,_, both_CC from_IN a_DT viral_JJ activator_NN standpoint_NN ,_, its_PP$ effect_NN on_IN few_JJ host_NN cellular_JJ genes_NNS ,_, and_CC its_PP$ effect_NN as_IN an_DT extracellular_JJ cytokine_NN ._SENT However_RB ,_, to_TO date_VB there_EX are_VBP no_RB reported_VBN Tat_NP gene_NN expression_NN analyses_NNS that_WDT detect_VBP more_JJR than_IN a_DT few_JJ cellular_JJ genes_NNS ._SENT We_PP performed_VBD our_PP$ microarray_NN analysis_NN first_JJ with_IN a_DT cDNA_NN blot_NN of_IN 588_CD genes_NNS ,_, which_WDT is_VBZ known_VBN to_TO contain_VB various_JJ receptors_NNS ,_, cytokines_NNS ,_, transcription_NN factors_NNS ,_, DNA_NN replication_NN genes_NNS ,_, and_CC other_JJ additional_JJ well_RB characterized_VBN genes_NNS ._SENT Figure_NN shows_VBZ the_DT results_NNS of_IN a_DT microarray_NN experiment_NN from_IN uninfected_JJ (_( CEM_NP )_) and_CC latently_RB HIV-1_JJ infected_JJ (_( ACH2_JJ )_) cells_NNS ._SENT By_IN definition_NN ,_, latently_RB HIV-1_JJ infected_JJ cells_NNS contain_VBP integrated_JJ HIV-1_JJ sequences_NNS in_IN the_DT host_NN genome_NN ._SENT To_TO our_PP$ surprise_NN ,_, we_PP detected_VBD many_JJ cellular_JJ genes_NNS that_WDT were_VBD down-regulated_VBN in_IN ACH2_JJ cells_NNS as_RB compared_VBN to_TO CEM_NP uninfected_JJ cells_NNS ._SENT ACH2_JJ cells_NNS ,_, similar_JJ to_TO many_JJ other_JJ latent_JJ HIV-1_JJ infected_JJ cells_NNS including_VBG U1_NP ,_, OM10.1_NP ,_, 8E5_JJ ,_, and_CC J1-1_NP ,_, express_JJ multiple_NN doubly_RB spliced_VBD messages_NNS including_VBG Tat_NP ,_, Rev_NP ,_, Nef_NP ,_, and_CC Vpr_NP ._SENT Therefore_RB ,_, it_PP would_MD be_VB difficult_JJ to_TO determine_VB which_WDT one_CD of_IN these_DT viral_JJ open_JJ reading_NN frames_NNS was_VBD in_IN fact_NN controlling_VBG the_DT observed_JJ changes_NNS in_IN host_NN gene_NN expression_NN ._SENT Figure_NP 1_CD |_SYM Gene_NP expression_NN analysis_NN of_IN uninfected_JJ and_CC HIV-1_JJ infected_JJ cells_NNS ._SENT Gene_NN expression_NN analysis_NN of_IN uninfected_JJ and_CC HIV-1_JJ infected_JJ cells_NNS ._SENT A_NP )_) Both_CC CEM_NP (_( uninfected_JJ )_) and_CC ACH2_NP (_( latently_RB HIV-1_NP infected_VBD )_) cells_NNS were_VBD grown_VBN to_TO mid-log_NN phase_NN of_IN growth_NN and_CC processed_VBN for_IN RNA_NP isolation_NN ._SENT Total_NP RNA_NP was_VBD labeled_VBN with_IN 32P-ATP_JJ and_CC hybridized_VBN to_TO human_JJ cDNA_NN filters_NNS (_( Clontech_NP ,_, 588_CD genes_NNS )_) ._SENT Blots_NNS were_VBD hybridized_VBN overnight_RB ,_, washed_VBD the_DT next_JJ day_NN ,_, and_CC exposed_VBN to_TO a_DT PhosphorImager_NP cassette_NN ._SENT B_LS )_) Same_JJ as_IN in_IN panel_NN A_DT ,_, except_IN all_PDT the_DT 588_CD genes_NNS were_VBD plotted_VBN as_IN fold_NN change_NN vs._CC gene_NN index_NN (_( individual_JJ genes_NNS )_) ._SENT Examples_NNS of_IN three_CD genes_NNS such_JJ as_IN prothymosin-alpha_NN ,_, C-myc_NP ,_, and_CC p21/Waf1_JJ ,_, is_VBZ shown_VBN on_IN the_DT diagram_NN ._SENT C_LS )_) Northern_JJ blot_NN analysis_NN of_IN prothymosin-alpha_NN ,_, C-myc_NP ,_, p21/Waf1_NN and_CC ubiquitin_NN using_VBG 10_CD mug_NN of_IN total_JJ RNA_NP ,_, separated_VBN on_IN 0.8_CD %_NN formaldehyde_NN gel_NN ,_, and_CC probed_VBD with_IN 40_CD mer_NN anti-sense_JJ oligos_NNS against_IN respective_JJ genes_NNS ._SENT Bottom_NN of_IN panel_NN C_NP ,_, last_JJ insert_NN shows_VBZ RNA_NP ethidium_NN bromide_NN stain_NN from_IN CEM_NP and_CC ACH2_NP cells_NNS ._SENT Nonetheless_RB ,_, when_WRB mapping_VBG all_PDT the_DT 588_CD genes_NNS ,_, we_PP found_VBD that_IN 139_CD genes_NNS were_VBD activated_VBN above_IN 1_CD fold_NN and_CC 449_CD genes_NNS were_VBD expressed_VBN below_IN 1_CD fold_NN ._SENT This_DT is_VBZ in_IN sharp_JJ contrast_NN to_TO latent_JJ HTLV-1_JJ infected_JJ Tax_NN expressing_VBG cells_NNS ,_, where_WRB more_JJR than_IN two-thirds_NNS of_IN the_DT same_JJ set_NN of_IN genes_NNS were_VBD activated_VBN and_CC scored_VBN above_IN one_CD ._SENT Some_DT of_IN the_DT genes_NNS from_IN HIV-1_JJ latent_JJ cells_NNS were_VBD further_RBR processed_VBN as_IN control_NN experiments_NNS using_VBG Northern_JJ blot_NN analysis_NN ._SENT As_RB can_MD be_VB seen_VBN in_IN Figure_NN ,_, and_CC consistent_JJ with_IN previously_RB published_VBN reports_NNS ,_, p21/Waf1_NN was_VBD down-regulated_JJ and_CC C-myc_NP and_CC pro-thymosin-alpha_NP were_VBD up-regulated_VBN in_IN HIV-1_JJ latent_JJ cells_NNS ._SENT Collectively_RB ,_, these_DT experiments_NNS point_NN toward_IN host_NN cellular_JJ changes_NNS in_IN the_DT presence_NN of_IN doubly_RB spliced_VBN HIV-1_NP RNA_NP ;_: however_RB they_PP do_VBP not_RB explain_VB whether_IN Tat_NP or_CC other_JJ viral_JJ genes_NNS are_VBP responsible_JJ for_IN the_DT observed_JJ cellular_JJ changes_NNS ._SENT Therefore_RB ,_, we_PP focused_VBD our_PP$ attention_NN on_IN HIV-1_NP Tat_NP protein_NN ,_, since_IN Tat_NP could_MD readily_RB be_VB detected_VBN in_IN immunoprecipitations_NNS from_IN 35S_JJ labeled_VBN latent_JJ ACH2_NP ,_, U1_NP ,_, OM10.1_NP ,_, 8E5_JJ ,_, and_CC J1-1_JJ cells_NNS (_( 20_CD ,_, data_NNS not_RB shown_VBN )_) ._SENT We_PP utilized_VBD a_DT well-characterized_JJ system_NN of_IN H9_NP and_CC H9/Tat_NP cell_NN lines_NNS for_IN our_PP$ next_JJ set_NN of_IN microarray_NN experiments_NNS and_CC increased_VBD our_PP$ repertoire_NN of_IN the_DT known_VBN cDNA_NN genes_NNS from_IN 588_CD to_TO 2400_CD ._SENT This_DT was_VBD accomplished_VBN by_IN using_VBG glass_NN slides_NNS which_WDT were_VBD printed_VBN with_IN cDNAs_NNS of_IN 500_CD bases_NNS or_CC higher_JJR ,_, and_CC could_MD be_VB used_VBN in_IN hybridization_NN with_IN two_CD different_JJ sets_NNS of_IN RNAs_NP labeled_VBD with_IN either_DT Tyramide_NN linked_VBN Cy-3_NP or_CC Cy-5_NP ._SENT Results_NNS of_IN such_PDT an_DT experiment_NN is_VBZ shown_VBN in_IN Figure_NP ,_, where_WRB H9_NP cytoplasmic_JJ Poly_NP A+_NP selected_VBD RNA_NP was_VBD labeled_VBN with_IN Cy-5_NP and_CC the_DT H9/Tat_NP RNA_NP with_IN Cy-3_NP prior_RB to_TO hybridization_NN ._SENT When_WRB all_PDT the_DT 2400_CD genes_NNS were_VBD plotted_VBN ,_, some_DT 695_CD genes_NNS were_VBD shown_VBN to_TO be_VB up-regulated_VBN above_IN one_CD fold_NN and_CC 1705_CD genes_NNS were_VBD down-regulated_JJ below_IN one_CD fold_NN (_( right_JJ hand_NN graphs_NNS )_) ._SENT This_DT was_VBD consistent_JJ with_IN the_DT results_NNS obtained_VBN from_IN the_DT ACH2_NP microarray_NN experiment_NN ,_, where_WRB more_JJR than_IN 2/3_CD of_IN the_DT cellular_JJ genes_NNS were_VBD down-regulated_JJ by_IN one_CD or_CC more_JJR of_IN the_DT doubly_RB spliced_VBN genes_NNS ._SENT We_PP then_RB arbitrarily_RB chose_VBD a_DT cut-off_NN of_IN three_CD fold_NN change_NN for_IN our_PP$ next_JJ set_NN of_IN analyses_NNS ._SENT This_DT was_VBD mainly_RB because_RB many_JJ of_IN our_PP$ in_IN house_NN microarray_NN experiments_NNS with_IN HIV-1_NP ,_, HTLV-1_NP ,_, and_CC HHV-8_NP infection_NN has_VBZ shown_VBN a_DT reproducible_JJ correlation_NN between_IN protein_NN and_CC mRNA_NN levels_NNS when_WRB gene_NN expression_NN levels_NNS were_VBD up-_JJ or_CC down-regulated_JJ by_IN more_JJR than_IN three_CD fold_NN (_( data_NNS not_RB shown_VBN )_) ._SENT A_DT collection_NN of_IN all_PDT the_DT genes_NNS above_IN and_CC below_IN three_CD fold_NN are_VBP shown_VBN in_IN Tables_NP ,_, ,_, and_NP ._SENT Based_VBN on_IN existing_VBG literature_NN ,_, we_PP categorized_VBD all_RB of_IN these_DT genes_NNS into_IN known_JJ pathways_NNS ._SENT For_IN instance_NN ,_, genes_NNS in_IN Table_NP belong_VBP to_TO receptors_NNS ,_, co-receptors_NNS ,_, and_CC co-activators_NNS ,_, genes_NNS in_IN Table_NP are_VBP all_PDT the_DT translation_NN related_VBN factors_NNS ,_, and_CC those_DT in_IN Table_NP indicate_VBP genes_NNS that_WDT are_VBP involved_VBN in_IN cytoskeleton_NN ,_, signal_NN transduction_NN ,_, cell_NN cycle_NN ,_, DNA_NN repair_NN ,_, transcription_NN ,_, and_CC chromatin_NN remodeling_NN processes_NNS ._SENT All_DT genes_NNS have_VBP a_DT number_NN ratio_NN of_IN Cy3_NP to_TO Cy5_NP (_( C3/C5_NP )_) indicating_VBG a_DT ratio_NN of_IN mRNA_NN from_IN H9/Tat_NP over_IN H9_NP cells_NNS ._SENT A_DT brief_JJ name_NN description_NN and_CC gene_NN ID_NN accession_NN number_NN is_VBZ given_VBN to_TO the_DT right_JJ hand_NN side_NN of_IN each_DT ratio_NN ._SENT All_DT genes_NNS are_VBP divided_VBN into_IN up_RB (_( 3_CD fold_NN and_CC higher_JJR )_) and_CC down_RB (_( 3_LS fold_VB and_CC lower_VB )_) regulated_VBN in_IN Tat_NP expressing_VBG cells_NNS ._SENT Below_RB is_VBZ a_DT brief_JJ description_NN of_IN genes_NNS that_IN we_PP ,_, along_RB with_IN the_DT existing_JJ literature_NN ,_, were_VBD able_JJ to_TO correlate_VB with_IN proliferative_JJ and/or_CC differentiation_NN signals_NNS ._SENT Figure_NP 2_CD |_SYM Gene_NP expression_NN analysis_NN from_IN Tat_NP expressing_VBG cells_NNS ._SENT Gene_NN expression_NN analysis_NN from_IN Tat_NP expressing_VBG cells_NNS ._SENT Both_DT H9_NP and_CC H9/Tat_NP cells_NNS were_VBD grown_VBN to_TO mid-log_NN phase_NN of_IN growth_NN ,_, processed_VBN for_IN RNA_NP preparation_NN ,_, and_CC labeled_VBN with_IN Tyramide_NN linked_VBN Cy-5_NP (_( H9_NP )_) or_CC Cy-3_NP (_( H9/TAT_NP )_) ._SENT Labeled_VBN RNAs_NP were_VBD hybridized_VBN simultaneously_RB to_TO a_DT glass_NN slide_NN containing_VBG 2400_CD known_VBN cDNA_NN genes_NNS (_( NEN_NP Inc._NP )_) ._SENT All_DT genes_NNS were_VBD plotted_VBN similar_JJ to_TO Figure_NN and_CC genes_NNS above_IN &_CC below_IN 1_CD fold_NN change_NN were_VBD plotted_VBN (_( on_IN the_DT right_JJ hand_NN side_NN )_) to_TO show_VB activation_NN and_CC suppression_NN of_IN all_DT genes_NNS ._SENT Table_NP 1_CD |_SYM Receptors_NP Table_NP 2_CD |_SYM Translation_NN Factors_NP Table_NP 3_CD |_SYM Receptor_JJ family_NN members_NNS |_SYM It_PP has_VBZ long_RB been_VBN known_VBN that_DT infection_NN by_IN HIV-1_NP commonly_RB leads_VBZ to_TO the_DT down-regulation_NN and_CC the_DT disappearance_NN of_IN CD4_NP receptors_NNS from_IN the_DT plasma_NN membrane_NN ,_, a_DT phenomenon_NN referred_VBD to_TO as_IN receptor_NN down-modulation_NN ._SENT This_DT ,_, in_IN turn_NN ,_, renders_VBZ cells_NNS refractory_JJ to_TO subsequent_JJ infection_NN by_IN the_DT same_JJ or_CC other_JJ viruses_NNS that_WDT use_VBP the_DT CD4_NP receptor_NN for_IN entry_NN ;_: thus_RB creating_VBG a_DT state_NN of_IN super-infection_NN immunity_NN ._SENT Results_NNS in_IN Table_NP indicate_VBP that_IN although_IN few_JJ receptor_NN genes_NNS were_VBD up-regulated_VBN ,_, most_JJS of_IN the_DT cellular_JJ receptors_NNS in_IN general_JJ ,_, were_VBD down-regulated_VBN in_IN the_DT presence_NN of_IN the_DT Tat_NP protein_NN ._SENT Most_JJS of_IN these_DT receptors_NNS or_CC membranous_JJ proteins_NNS were_VBD initially_RB discovered_VBN from_IN immune_JJ or_CC neuronal_JJ cells_NNS ,_, hence_RB they_PP were_VBD given_VBN names_NNS related_VBN to_TO the_DT immune_JJ or_CC nervous_JJ system_NN ._SENT For_IN instance_NN ,_, mRNA_NN for_IN the_DT neuropeptide_NN Y-like_JJ receptor_NN (_( Acc#_NP X71635_NP )_) ,_, which_WDT was_VBD up-regulated_VBN in_IN Tat_NP expressing_VBG cells_NNS ,_, was_VBD initially_RB discovered_VBN as_IN a_DT G-protein_NP coupled_VBN neuropeptide_NN Y_NN receptor_NN ,_, and_CC later_RBR found_VBD to_TO be_VB homologous_JJ to_TO the_DT co-receptor_NN CCR5_NN needed_VBN for_IN HIV-1_JJ infection_NN of_IN monocyte/macrophage_NN cells_NNS ._SENT Therefore_RB ,_, most_JJS of_IN the_DT receptors_NNS listed_VBN in_IN Table_NP may_MD in_IN fact_NN be_VB expressed_VBN in_IN various_JJ tissues_NNS and_CC have_VBP multiple_JJ functions_NNS ._SENT Consistent_JJ with_IN our_PP$ microarray_NN results_NNS on_IN CCR5_NP up-regulation_NN ,_, experiments_NNS performed_VBN in_IN peripheral_JJ blood_NN mononuclear_JJ cells_NNS (_( PBMCs_NP )_) with_IN soluble_JJ Tat_NP has_VBZ shown_VBN selective_JJ entry_NN and_CC replication_NN of_IN CCR5_NP virus_NN into_IN cells_NNS ._SENT Up-regulation_NN of_IN HIV-1_JJ coreceptor_NN by_IN Tat_NP has_VBZ also_RB been_VBN reported_VBN ,_, where_WRB a_DT synthetic_JJ Tat_NP protein_NN that_WDT was_VBD immobilized_VBN on_IN a_DT solid_JJ substrate_NN ,_, up-regulated_VBD the_DT surface_NN expression_NN of_IN the_DT chemokine_JJ receptors_NNS in_IN purified_VBN populations_NNS of_IN primary_JJ resting_JJ CD4+_NP T_NN cells_NNS ._SENT Also_RB ,_, a_DT similar_JJ result_NN was_VBD seen_VBN from_IN Tat_NP protein_NN actively_RB released_VBN by_IN HIV-1_JJ infected_JJ cells_NNS ,_, implying_VBG a_DT potentially_RB important_JJ role_NN for_IN extracellular_JJ Tat_NP in_IN rendering_VBG the_DT bystander_NN CD4+_NP T_NN cells_NNS more_RBR susceptible_JJ to_TO infection_NN ._SENT We_PP therefore_RB tested_VBD whether_IN H9/Tat_NP cells_NNS ,_, which_WDT showed_VBD an_DT increase_NN in_IN CCR5_NP expression_NN ,_, could_MD in_IN fact_NN allow_VBP better_JJR entry_NN and_CC infection_NN of_IN the_DT CCR5_NP (_( R5_NP )_) virus_NN into_IN cells_NNS ._SENT Figure_NN shows_VBZ the_DT result_NN of_IN such_PDT an_DT experiment_NN ,_, where_WRB H9/Tat_NP cells_NNS allowed_VBD a_DT better_JJR replication_NN profile_NN of_IN the_DT R5_NP than_IN the_DT CXCR4_NP (_( X4_NP )_) virus_NN ._SENT The_DT increase_NN in_IN viral_JJ titer_NN peaked_VBN after_IN some_DT 18_CD days_NNS of_IN infection_NN with_IN the_DT R5_NP virus_NN ,_, further_RBR implying_VBG that_IN the_DT CCR5_NP co-receptor_NN allowed_VBD a_DT better_JJR selection_NN of_IN R5_NP virus_NN in_IN Tat_NP expressing_VBG cells_NNS ._SENT Figure_NP 3_CD |_SYM Functional_JJ and_CC physical_JJ confirmation_NN of_IN few_JJ genes_NNS from_IN Tat_NP expressing_VBG cells_NNS ._SENT Functional_JJ and_CC physical_JJ confirmation_NN of_IN few_JJ genes_NNS from_IN Tat_NP expressing_VBG cells_NNS ._SENT A_NP )_) Infection_NN of_IN mono-_NN and_CC T-tropic_JJ viruses_NNS into_IN Tat_NP expressing_VBG cells_NNS ._SENT Both_DT HXB-2_NP and_CC BaL_NP strains_NNS of_IN HIV-1_NP were_VBD infected_VBN into_IN H9_NP and_CC H9/TAT_NP cells_NNS ._SENT Supernatants_NNS were_VBD collected_VBN every_DT 3_CD days_NNS and_CC further_RBR processed_JJ for_IN p24_JJ gag_NN ELISA_NP assays_VBZ ._SENT B_LS )_) Western_JJ blot_NN analysis_NN from_IN H9_NP and_CC H9/TAT_NP expressing_VBG cells_NNS using_VBG co-activators_NNS (_( SRC-1_NP )_) ,_, DNA_NN damage_NN (_( DNA-PK_NP )_) ,_, activator_NN (_( p300_NN )_) ,_, and_CC signal_NN transduction_NN (_( Ras_NP ,_, RAF_NN ,_, and_CC MAPK_NP )_) antibodies_NNS ._SENT TBP_NP stands_VBZ for_IN TATA_NP binding_JJ protein_NN ,_, which_WDT served_VBD as_IN positive_JJ control_NN in_IN western_JJ blots_NNS ._SENT C_LS )_) Western_JJ blot_NN analysis_NN from_IN CEM_NP (_( uninfected_JJ T-cell_NN )_) ,_, ACH2_NP (_( infected_JJ T-cell_NN )_) ,_, U937_JJ (_( uninfected_JJ promonocytic_NN )_) ,_, U1_NP (_( infected_JJ promonocytic_NN )_) ,_, and_CC PBMCs_NNS treated_VBN with_IN purified_VBN Tat_NP wild_JJ type_NN or_CC K41A_NP mutant_NN (_( 100_CD ng/ml_NNS )_) proteins_NNS ._SENT Fifty_CD microgram_NN of_IN whole_JJ cells_NNS lysates_NNS were_VBD processed_VBN for_IN western_JJ blots_NNS with_IN anti-DNA-PK_NN ,_, p300_NN ,_, RAF_NN ,_, and_CC TBP_NP antibodies_NNS ._SENT Another_DT example_NN of_IN co-receptors_NNS with_IN multiple_JJ functions_NNS is_VBZ the_DT leukotriene_NN family_NN member_NN B4_NP ,_, which_WDT was_VBD down-regulated_VBN in_IN Tat_NP expressing_VBG cells_NNS (_( Acc#_NP D89078_NP ,_, Table_NP )_) ._SENT The_DT cysteinyl_NN leukotrienes_NNS (_( CysLT_NP )_) ,_, LTC_NP ,_, LTD_NP ,_, and_CC LTE_NP ,_, were_VBD first_RB shown_VBN to_TO be_VB essential_JJ mediators_NNS in_IN asthma_NN ._SENT However_RB ,_, when_WRB the_DT mouse_NN leukotriene_NN B4_NP receptor_NN (_( m-BLTR_NN )_) gene_NN ,_, was_VBD cloned_VBN it_PP was_VBD shown_VBN to_TO have_VB significant_JJ sequence_NN homology_NN with_IN chemokine_JJ receptors_NNS (_( CCR5_NP and_CC CXCR4_NP )_) ,_, co-receptors_NNS for_IN many_JJ different_JJ HIV-1_JJ clades_NNS ._SENT Along_IN the_DT same_JJ lines_NNS ,_, when_WRB cells_NNS were_VBD infected_VBN with_IN 10_CD primary_JJ clinical_JJ isolates_NNS of_IN HIV-1_NP ,_, leukotriene_JJ B4_NP receptor_NN was_VBD primarily_RB utilized_VBN for_IN efficient_JJ entry_NN into_IN cells_NNS which_WDT were_VBD mainly_RB of_IN the_DT syncytium-inducing_NN phenotype_NN ._SENT Therefore_RB ,_, up-regulation_NN of_IN neuropeptide_NN Y-like_JJ receptor_NN and_CC down-regulation_NN of_IN leukotriene_JJ B4_NP receptor_NN in_IN Tat_NP expressing_VBG cells_NNS indicates_VBZ a_DT selective_JJ advantage_NN of_IN one_CD class_NN of_IN virus_NN (_( CCR5_NP )_) over_IN another_DT (_( CXCR4_NP )_) ._SENT Other_JJ examples_NNS of_IN consistency_NN between_IN our_PP$ microarray_NN results_NNS on_IN receptors_NNS and_CC the_DT HIV-1_NP Tat_NP literature_NN ,_, include_VBP the_DT down-regulation_NN of_IN gene_NN expression_NN in_IN uPAR_NP (_( Acc#_NP X74039_NP )_) ,_, IP3_NP (_( Acc#_NP D26070_NP ,_, D26351_NP )_) ,_, Glu_NP R_NP flop_NN (_( Acc#_NP U10302_NP )_) ,_, PPAR_NP (_( Acc#_NP L07592_NP )_) ,_, alpha-2_JJ macroglobulin_NN receptor_NN protein_NN (_( Acc#_NP M63959_NP )_) ,_, and_CC receptor_NN tyrosine_NN kinase_NN (_( Acc#_NP L36645_NP ,_, U66406_NP )_) genes_NNS ._SENT The_DT transmembranous_JJ urokinase-type_NN plasminogen_NN activator_NN receptor_NN (_( uPAR_NP ;_: CD87_NP )_) focuses_VBZ the_DT formation_NN of_IN active_JJ plasmin_NN at_IN the_DT cell_NN surface_NN ,_, thus_RB enhancing_VBG directional_JJ extracellular_JJ proteolysis_NN ._SENT Interestingly_RB ,_, the_DT promoter_NN activity_NN of_IN the_DT CD87_JJ gene_NN was_VBD shown_VBN to_TO decline_VB after_IN infection_NN ,_, implying_VBG that_IN post_NN integration_NN of_IN HIV-1_NP may_MD in_IN fact_NN down-regulate_JJ CD87_JJ gene_NN expression_NN ._SENT Similarly_RB ,_, inositol_NN 1,4,5-trisphosphate_NN receptors_NNS (_( IP3R_NP )_) are_VBP intracellular_JJ calcium_NN release_NN channels_NNS involved_VBN in_IN diverse_JJ signaling_VBG pathways_NNS and_CC are_VBP required_VBN for_IN the_DT activation_NN of_IN T_NN lymphocytes_NNS ._SENT Tat_NP (_( also_RB implicated_VBN as_IN a_DT neurotoxin_NN )_) has_VBZ been_VBN shown_VBN to_TO release_VB calcium_NN from_IN inositol_NN 1,4_CD ,_, 5-trisphosphate_NN (_( IP3_NP )_) receptor-regulated_JJ stores_NNS in_IN neurons_NNS and_CC astrocytes_NNS causing_VBG premature_JJ apoptosis_NN ._SENT Down-regulation_NN of_IN IP3_NP may_MD therefore_RB contribute_VB to_TO viral_JJ latency_NN and_CC maintenance_NN of_IN an_DT anti-apoptotic_JJ state_NN in_IN cells_NNS ._SENT HIV-1_JJ infection_NN can_MD cause_VB extensive_JJ neuronal_JJ loss_NN and_CC clinically_RB ,_, a_DT severe_JJ dementia_NN ._SENT The_DT cause_NN of_IN the_DT neurotoxicity_NN remains_VBZ unclear_JJ as_IN neurons_NNS are_VBP not_RB infected_VBN ,_, but_CC the_DT disturbance_NN of_IN glutamate-linked_JJ calcium_NN entry_NN has_VBZ been_VBN implicated_VBN ._SENT It_PP has_VBZ been_VBN shown_VBN that_IN HIV-infected_JJ brain_NN has_VBZ a_DT decrease_NN of_IN mRNA_NN and_CC protein_NN of_IN the_DT GluR-A_NP flop_NN subtype_NN of_IN alpha-amino-3-hydroxy-5-methyl-4-isoxazole_NN propionic_JJ acid_NN (_( AMPA_NP )_) glutamate_NN receptor_NN in_IN cerebellar_JJ Purkinje_NP cells_NNS ._SENT The_DT observed_JJ disturbance_NN of_IN AMPA_NP receptors_NNS may_MD contribute_VB to_TO the_DT neurotoxic_JJ process_NN in_IN other_JJ vulnerable_JJ brain_NN regions_NNS and_CC clinically_RB to_TO the_DT development_NN of_IN dementia_NN ._SENT Interestingly_RB ,_, in_IN a_DT mouse_NN model_NN AMPA_NP receptors_NNS in_IN the_DT cortex_NN ,_, striatum_NN ,_, hippocampus_NN ,_, and_CC cerebellum_NN declined_VBD by_IN 29_CD --_: 50_CD %_NN as_IN early_JJ as_IN 8_CD weeks_NNS post-retroviral_JJ inoculation_NN ._SENT Thus_RB ,_, the_DT reduction_NN in_IN AMPA_NP receptor_NN density_NN may_MD contribute_VB to_TO the_DT development_NN of_IN the_DT cognitive_JJ abnormalities_NNS associated_VBN with_IN HIV-1_JJ infection_NN ._SENT Finally_RB ,_, patients_NNS with_IN AIDS_NP who_WP are_VBP receiving_VBG therapy_NN with_IN HIV-1_JJ protease_NN inhibitors_NNS have_VBP been_VBN reported_VBN to_TO be_VB afflicted_VBN with_IN a_DT syndrome_NN characterized_VBN by_IN lipodystrophy_NN (_( fat_JJ redistribution_NN favoring_VBG the_DT accumulation_NN of_IN abdominal_JJ and_CC cervical_JJ adipose_JJ tissue_NN )_) ,_, hyperlipidemia_NN ,_, and_CC insulin_NN resistance_NN ._SENT Potential_JJ mechanisms_NNS for_IN altered_JJ adipocyte_NN function_NN include_VBP ,_, direct_JJ binding_NN to_TO PPARgamma_NP or_CC inhibition_NN of_IN transcription_NN of_IN PPARgamma_NP promoter_NN ._SENT The_DT lipodystrophy_NN syndrome_NN may_MD be_VB a_DT result_NN of_IN the_DT inhibition_NN of_IN 2_CD proteins_NNS involved_VBN in_IN lipid_NN metabolism_NN that_WDT have_VBP significant_JJ homology_NN to_TO the_DT catalytic_JJ site_NN of_IN HIV_NP proteases_NNS ;_: namely_RB cytoplasmic_JJ retinoic_JJ acid_NN binding_VBG protein_NN type_NN 1_CD and_CC low_JJ density_NN lipoprotein-receptor-related_JJ protein_NN ._SENT An_DT additional_JJ mechanism_NN of_IN PPAR_NP down-regulation_NN may_MD be_VB related_VBN to_TO Tat_NP expression_NN in_IN latent_JJ cells_NNS ._SENT Translation_NN associated_JJ factors_NNS |_SYM Viruses_NNS have_VBP evolved_VBN a_DT remarkable_JJ variety_NN of_IN strategies_NNS to_TO modulate_VB the_DT host_NN cell_NN translation_NN apparatus_NN with_IN the_DT aim_NN of_IN optimizing_VBG viral_JJ mRNA_NN translation_NN and_CC replication_NN ._SENT For_IN instance_NN ,_, viruses_NNS including_VBG Herpes_NP simplex_JJ virus_NN type_NN 1_CD (_( HSV-1_NP )_) have_VBP been_VBN known_VBN to_TO induce_VB severe_JJ alterations_NNS of_IN the_DT host_NN translational_JJ apparatus_NN ,_, including_VBG the_DT up-regulation_NN of_IN ribosomal_JJ proteins_NNS and_CC the_DT progressive_JJ association_NN of_IN several_JJ nonribosomal_JJ proteins_NNS ,_, such_JJ as_IN VP19C_NP ,_, VP26_NP ,_, and_CC the_DT poly(A)-binding_NN protein_NN 1_CD (_( PAB1P_NP )_) to_TO ribosomes_NNS ._SENT In_IN the_DT case_NN of_IN HIV-1_NP ,_, approximately_RB one_CD infectious_JJ HIV-1_JJ genome_NN in_IN an_DT infected_JJ cell_NN could_MD be_VB transcribed_VBN and_CC translated_VBN into_IN 50,000_CD to_TO 100,000_CD physical_JJ particles_NNS ._SENT This_DT poses_VBZ an_DT immense_JJ challenge_NN for_IN the_DT virus_NN to_TO be_VB able_JJ to_TO transcribe_VB ,_, splice_VB ,_, transport_VB ,_, and_CC translate_VB its_PP$ RNA_NP into_IN fully_RB packaged_VBN virions_NNS in_IN a_DT timely_JJ fashion_NN ._SENT Therefore_RB ,_, it_PP would_MD be_VB advantageous_JJ for_IN the_DT virus_NN to_TO set_VB the_DT stage_NN for_IN each_DT successive_JJ step_NN necessary_JJ for_IN viral_JJ progeny_NN formation_NN ._SENT One_CD such_JJ event_NN is_VBZ Tat_NP 's_POS ability_NN to_TO control_VB genes_NNS that_IN aid_NN in_IN translational_JJ machinery_NN ._SENT As_IN seen_VBN in_IN Table_NP ,_, many_JJ of_IN the_DT critical_JJ components_NNS of_IN a_DT functional_JJ ribosome_NN ,_, including_VBG large_JJ subunits_NN L_NP 3_CD ,_, 6_CD ,_, 26_CD ,_, 31_CD ,_, 38_CD ,_, and_CC 41_CD ,_, as_RB well_RB as_IN S_NP 6_CD ,_, 12_CD ,_, 20_CD ,_, and_CC 24_CD ,_, and_CC many_JJ of_IN the_DT translation_NN initiation_NN factors_NNS are_VBP up-regulated_JJ by_IN Tat_NP ._SENT This_DT would_MD imply_VB that_IN Tat_NP up-regulates_VBZ many_JJ ribosomal_JJ genes_NNS that_WDT may_MD be_VB necessary_JJ to_TO produce_VB functional_JJ ribosomes_NNS needed_VBN for_IN viral_JJ mRNA_NN translation_NN ._SENT Therefore_RB ,_, interfering_VBG with_IN translation_NN could_MD provide_VB a_DT new_JJ strategy_NN for_IN anti-HIV_NP treatment_NN ._SENT Along_IN these_DT lines_NNS ,_, when_WRB the_DT aminogylcosides_NNS (_( kanamycin_NN ,_, hygromycin_NP B_NP ,_, paromycin_NN and_CC neomycin_NN )_) due_JJ to_TO their_PP$ ability_NN to_TO inhibit_VB protein_NN synthesis_NN by_IN affecting_VBG ribosomal_JJ fidelity_NN ,_, or_CC puromycin_NN because_IN of_IN its_PP$ competing_VBG ability_NN with_IN tRNAs_NNS for_IN binding_VBG on_IN the_DT large_JJ ribosomal_JJ subunit_NN ,_, or_CC cycloheximide_NN which_WDT inhibit_VBP the_DT large_JJ ribosomal_JJ subunit_NN by_IN preventing_VBG ribosomal_JJ movement_NN along_IN the_DT mRNA_NN ,_, were_VBD used_VBN in_IN active_JJ HIV-1_JJ infection_NN ,_, it_PP was_VBD found_VBN that_IN both_DT cycloheximide_NN and_CC puromycin_NN produced_VBD the_DT greatest_JJS decrease_NN in_IN HIV-1_JJ inhibition_NN ,_, presumably_RB by_IN inhibiting_VBG the_DT large_JJ subunit_NN of_IN the_DT ribosome_NN ._SENT Translation_NN of_IN HIV-1_NP RNAs_NP pose_VB a_DT challenge_NN since_IN they_PP all_RB contain_VBP a_DT TAR_JJ sequence_NN at_IN their_PP$ 5_CD '_POS end_NN ._SENT The_DT Tat-responsive_JJ region_NN (_( TAR_NN )_) of_IN HIV-1_NP exhibits_VBZ a_DT trans-inhibitory_JJ effect_NN on_IN translation_NN by_IN activating_VBG the_DT interferon-induced_JJ 68-kilodalton_JJ protein_NN kinase_NN ._SENT Productive_JJ infection_NN by_IN HIV-1_NP has_VBZ been_VBN shown_VBN to_TO result_VB in_IN a_DT significant_JJ decrease_NN in_IN the_DT amount_NN of_IN cellular_JJ p68_NN kinase_NN ._SENT The_DT steady-state_NN amount_NN of_IN p68_JJ kinase_NN was_VBD found_VBN to_TO be_VB reduced_VBN in_IN cells_NNS stably_RB expressing_VBG Tat_NP ._SENT Thus_RB ,_, the_DT potential_JJ translational_JJ inhibitory_JJ effects_NNS of_IN the_DT TAR_NP RNA_NP region_NN ,_, mediated_VBN by_IN activation_NN of_IN p68_JJ kinase_NN ,_, may_MD be_VB down-regulated_VBN by_IN Tat_NP during_IN activation_NN of_IN the_DT latent_JJ virus_NN ._SENT Along_IN these_DT lines_NNS ,_, a_DT Tat_NP peptide_NN antagonist_NN ,_, which_WDT bound_VBD specifically_RB to_TO TAR_NP RNA_NP and_CC competed_VBN with_IN Tat_NP for_IN binding_NN ,_, reduced_VBD Tat-dependent_JJ translation_NN ._SENT Finally_RB ,_, upregulation_NN of_IN translation_NN genes_NNS in_IN Tat_NP expressing_VBG cells_NNS is_VBZ specially_RB intriguing_JJ in_IN light_NN of_IN the_DT recent_JJ discovery_NN of_IN internal_JJ ribosome_NN entry_NN sites_NNS (_( IRESs_NP )_) in_IN HIV-1_JJ gag_NN ORF_NP ._SENT IRESs_NP are_VBP thought_VBN to_TO promote_VB initiation_NN of_IN translation_NN by_IN directly_RB binding_VBG to_TO ribosomes_NNS ,_, in_IN a_DT manner_NN independent_JJ of_IN the_DT mRNA_NN cap_NN or_CC of_IN scanning_VBG through_IN upstream_JJ sequences_NNS ._SENT Since_RB ,_, the_DT TAR_NN is_VBZ located_VBN at_IN the_DT 5_CD '_POS end_NN of_IN all_DT HIV-1_NP RNA_NP transcripts_NNS and_CC the_DT presence_NN of_IN secondary_JJ structure_NN at_IN or_CC near_IN the_DT 5_CD '_POS end_NN of_IN RNAs_NP reduces_VBZ the_DT accessibility_NN of_IN the_DT 5_CD '_POS cap_NN to_TO eIF4F_NN ,_, it_PP is_VBZ thought_VBN that_IN this_DT feature_NN of_IN HIV-1_JJ mRNAs_NNS can_MD inhibit_VB their_PP$ cap-dependent_JJ translation_NN ._SENT Therefore_RB ,_, a_DT possible_JJ function_NN of_IN the_DT HIV-1_NP gag_NN IRES_NN might_MD be_VB to_TO serve_VB as_IN a_DT mechanism_NN to_TO bypass_VB the_DT structural_JJ barriers_NNS to_TO cap-dependent_JJ translation_NN by_IN recruiting_VBG ribosomes_NNS easily_RB and_CC directly_RB to_TO the_DT gag_NN ORFs_NNS ._SENT IRES_NNS entirely_RB contained_VBN within_IN a_DT translated_VBN ORF_NP has_VBZ been_VBN shown_VBN in_IN the_DT MMLV_NP gag_NN ,_, and_CC host_NN mRNA_NN encoding_VBG p110PITSLRE_NN and_CC p58PITSLRE_NN ._SENT Along_IN these_DT lines_NNS ,_, cap-dependent_JJ translation_NN may_MD be_VB cell_NN cycle_NN regulated_VBN ,_, especially_RB when_WRB cells_NNS are_VBP arrested_VBN at_IN the_DT G2_NP phase_NN of_IN the_DT cell_NN cycle_NN ,_, where_WRB the_DT cap-dependent_JJ translation_NN of_IN most_JJS cellular_JJ host_NN cell_NN mRNAs_NNS is_VBZ inhibited_VBN ._SENT Modulation_NN of_IN signal_NN transduction_NN pathway_NN |_SYM Results_NNS in_IN Table_NP indicate_VBP that_IN many_DT seemingly_RB different_JJ pathways_NNS are_VBP being_VBG regulated_VBN by_IN Tat_NP ._SENT However_RB ,_, the_DT signal_NN transduction_NN pathway_NN ,_, MAPK_NP ,_, has_VBZ been_VBN shown_VBN to_TO control_VB and_CC be_VB upstream_JJ of_IN DNA-replication_NP ,_, transcription_NN ,_, and_CC cell_NN cycle_NN pathways_NNS ._SENT The_DT mitogen-activated_JJ protein_NN kinase_NN (_( MAPK_NP )_) pathway_NN ,_, consisting_VBG of_IN the_DT MAP_NP kinase_NN kinases_NNS (_( MKKs_NP )_) 1_CD and_CC 2_CD ,_, and_CC extracellular_JJ signal-regulated_JJ kinases_NNS (_( ERKs_NP )_) 1_CD and_CC 2_CD ,_, which_WDT have_VBP been_VBN implicated_VBN in_IN diverse_JJ cellular_JJ processes_NNS including_VBG proliferation_NN ,_, transformation_NN ,_, and_CC cell_NN differentiation_NN ._SENT The_DT MAP_NP kinase_NN (_( MAPK_NP )_) pathway_NN has_VBZ emerged_VBN as_IN a_DT crucial_JJ route_NN between_IN membrane-bound_JJ Ras_NP and_CC the_DT nucleus_NN ._SENT This_DT MAPK_NP pathway_NN encompasses_VBZ a_DT cascade_NN of_IN phosphorylation_NN events_NNS involving_VBG three_CD key_JJ kinases_NNS ,_, namely_RB Raf_NP ,_, MEK_NP (_( MAP_NP kinase_NN kinase_NN )_) and_CC ERK_NP (_( MAP_NP kinase_NN )_) ._SENT The_DT MAPK_NP pathway_NN controls_VBZ ERKs_NP 1_CD and_CC 2_CD ,_, c-Jun_NP N-terminal_NP kinase_NN (_( JNK_NP )_) ,_, and_CC p38_NN ._SENT These_DT signaling_VBG pathways_NNS in_IN turn_NN ,_, activate_VBP a_DT variety_NN of_IN transcription_NN factors_NNS including_VBG NF-kappaB_NP (_( p50/p65_NN )_) ,_, AP-1_NP (_( c-Fos/c-Jun_NP )_) ,_, and_CC CREB_NP phosphorylation_NN ,_, which_WDT in_RB turn_VBP coordinate_VB the_DT induction_NN of_IN many_JJ genes_NNS encoding_VBG inflammatory_JJ mediators_NNS ._SENT Cytokine_NN receptors_NNS such_JJ as_IN IL-3_NP ,_, GM-CSF_NP ,_, and_CC the_DT interferons_NNS transmit_VBP their_PP$ regulatory_JJ signals_NNS primarily_RB by_IN the_DT receptor-associated_JJ Jak_NP family_NN of_IN tyrosine_NN kinases_NNS ,_, and_CC activate_VBP STAT_NP transcription_NN factors_NNS ._SENT Activated_VBN STAT5_JJ proteins_NNS are_VBP detected_VBN in_IN reduced_VBN levels_NNS in_IN lymphocytes_NNS recovered_VBN from_IN HIV-infected_JJ patients_NNS and_CC immunocompromised_JJ mice_NNS ._SENT Both_CC of_IN these_DT types_NNS of_IN receptor_NN signaling_VBG pathways_NNS have_VBP recently_RB been_VBN shown_VBN to_TO interact_VB with_IN serine/threonine_NN kinases_NNS such_JJ as_IN MAP_NP kinases_NNS ._SENT A_DT common_JJ intermediate_JJ pathway_NN initiating_VBG from_IN receptors_NNS to_TO the_DT nucleus_NN is_VBZ the_DT Ras/Raf/MEK/ERK_NP (_( MAPK_NP )_) cascade_NN ,_, which_WDT can_MD result_VB in_IN the_DT phosphorylation_NN and_CC activation_NN of_IN additional_JJ downstream_JJ kinases_NNS and_CC transcription_NN factors_NNS such_JJ as_IN p90Rsk_NP ,_, CREB_NP ,_, Elk_NP ,_, and_CC Egr-1_NP ._SENT Therefore_RB ,_, it_PP is_VBZ intriguing_JJ that_IN Tat_NP expressing_VBG cells_NNS show_VBP down-regulation_NN of_IN MAPK_NP components_NNS (_( Table_NP ,_, Figure_NP and_NP )_) ,_, essential_JJ mediators_NNS between_IN receptors_NNS and_CC nuclear_JJ transcription_NN factors_NNS ._SENT This_DT would_MD imply_VB that_DT latently_RB infected_JJ cells_NNS that_WDT express_VBP Tat_NP (_( doubly_RB spliced_VBN RNA_NP )_) and_CC not_RB the_DT whole_JJ virus_NN (_( all_DT three_CD classes_NNS of_IN the_DT RNA_NP )_) ,_, can_MD control_VB signal_NN transduction_NN related_VBN to_TO membrane_NN and_CC transcriptional_JJ signaling_VBG ._SENT Interestingly_RB ,_, Tat_NP ,_, through_IN the_DT RGD_JJ motif_NN ,_, which_WDT controls_VBZ integrin-based_JJ cell_NN signaling_VBG ,_, has_VBZ been_VBN reported_VBN to_TO mediate_VB the_DT activity_NN of_IN phosphotyrosine_NN phosphatase(s_NNS )_) ._SENT This_DT in_IN turn_NN which_WDT would_MD lead_VB to_TO a_DT decrease_NN in_IN the_DT levels_NNS of_IN phosphotyrosine-containing_NN proteins_NNS such_JJ as_IN ERK-2/p42MAPK_NP kinases_NNS ._SENT Cysteine-rich_JJ and_CC basic_JJ Tat_NP peptides_NNS have_VBP been_VBN shown_VBN to_TO inhibit_VB VEGF-induced_NP ERK_NP activation_NN and_CC mitogenesis_NN ._SENT These_DT peptides_NNS also_RB inhibited_VBD proliferation_NN ,_, angiogenesis_NN ,_, and_CC ERK_NP activation_NN induced_VBN by_IN basic_JJ fibroblast_NN growth_NN factor_NN with_IN similar_JJ potency_NN and_CC efficacy_NN ._SENT Consistent_JJ with_IN this_DT model_NN ,_, it_PP has_VBZ been_VBN shown_VBN that_DT treatment_NN of_IN neural_JJ cells_NNS with_IN culture_NN supernatants_NNS from_IN HAART-treated_JJ subjects_NNS ,_, which_WDT presumably_RB contain_VBP extracellular_JJ Tat_NP ,_, resulted_VBN in_IN down-regulation_NN of_IN the_DT JNK_NN ,_, AKT_NP ,_, and_CC ERK_NP kinases_NNS ._SENT Finally_RB ,_, activation_NN of_IN MAPKs_NP has_VBZ been_VBN shown_VBN to_TO activate_VB the_DT singly_RB spliced_VBN and_CC unspliced_JJ (_( genomic_JJ )_) latent_JJ HIV-1_JJ virus_NN ._SENT For_IN instance_NN ,_, the_DT signal_NN transduction_NN pathways_NNS that_WDT regulate_VBP the_DT switch_NN from_IN latent_JJ to_TO productive_JJ infection_NN have_VBP been_VBN linked_VBN to_TO MAPK_NP ._SENT The_DT induction_NN of_IN latent_JJ HIV-1_NP expression_NN has_VBZ been_VBN shown_VBN to_TO be_VB inhibited_VBN by_IN PD98059_NP and_CC U0126_NP ,_, specific_JJ inhibitors_NNS of_IN MAPK_NP activation_NN ._SENT The_DT MAPK_NP acts_NNS by_IN stimulating_VBG AP-1_NP and_CC a_DT subsequent_JJ physical_JJ and_CC functional_JJ interaction_NN of_IN AP-1_NP with_IN NF-kappaB_NP ,_, resulting_VBG in_IN a_DT complex_NN that_WDT synergistically_RB transactivates_VBZ the_DT HIV-1_NP ._SENT At_IN the_DT level_NN of_IN infection_NN and_CC entry_NN ,_, the_DT activation_NN of_IN MAPK_NP through_IN the_DT Ras/Raf/MEK_NP (_( MAPK_NP kinase_NN )_) signaling_VBG pathway_NN enhances_VBZ the_DT infectivity_NN of_IN HIV-1_JJ virions_NNS ._SENT Virus_NN infectivity_NN can_MD be_VB enhanced_VBN by_IN treatment_NN of_IN cells_NNS with_IN MAPK_NP stimulators_NNS ,_, such_JJ as_IN serum_NN and_CC phorbol_NN myristate_NN acetate_NN ,_, as_RB well_RB as_IN by_IN coexpression_NN of_IN constitutively_RB activated_VBN Ras_NP ,_, Raf_NP ,_, or_CC MEK_NP in_IN the_DT absence_NN of_IN extracellular_JJ stimulation_NN ._SENT Also_RB ,_, following_VBG infection_NN ,_, efficient_JJ disengagement_NN of_IN the_DT reverse_JJ transcription_NN complex_NN from_IN the_DT cell_NN membrane_NN and_CC subsequent_JJ nuclear_JJ translocation_NN ,_, requires_VBZ phosphorylation_NN of_IN the_DT reverse_JJ transcription_NN complex_JJ components_NNS by_IN ERK/MAPK_NP ;_: demonstrating_VBG a_DT critical_JJ regulation_NN of_IN an_DT early_JJ step_NN in_IN HIV-1_JJ infection_NN by_IN the_DT host_NN cell_NN MAPK_NP signal_NN transduction_NN pathway_NN ._SENT Therefore_RB ,_, Tat_NP down-regulation_NN of_IN the_DT MAPK_NP pathway_NN in_IN latent_JJ cells_NNS implies_VBZ that_IN much_RB of_IN the_DT host_NN signal_NN transductions_NNS connected_VBN to_TO activation_NN are_VBP down-regulated_JJ ,_, and_CC at_IN the_DT same_JJ time_NN ,_, these_DT cells_NNS may_MD be_VB refractory_JJ to_TO subsequent_JJ infection_NN by_IN other_JJ viruses_NNS ._SENT Thymosin_NP family_NN members_NNS ,_, and_CC cell_NN cycle_NN |_SYM Prothymosin_NP alpha_NN (_( ProTalpha_NP )_) belongs_VBZ to_TO the_DT alpha-Thymosin_NN family_NN which_WDT comprises_VBZ different_JJ polypeptides_NNS widely_RB distributed_VBN within_IN animal_JJ tissues_NNS ._SENT Although_IN its_PP$ role_NN has_VBZ remained_VBN controversial_JJ ,_, it_PP is_VBZ involved_VBN in_IN the_DT increase_NN of_IN immediate_JJ early_JJ genes_NNS such_JJ as_IN c-myc_NP ,_, which_WDT is_VBZ upstream_RB of_IN cyclin_NN D_NP synthesis_NN and_CC necessary_JJ for_IN cell_NN division_NN ._SENT In_IN humans_NNS ,_, ProTalpha_NP is_VBZ coded_VBN by_IN a_DT gene_NN family_NN of_IN six_CD members_NNS ._SENT One_CD of_IN them_PP contains_VBZ introns_NNS ,_, exons_NNS and_CC classic_JJ regulatory_JJ signals_NNS ,_, while_IN the_DT remaining_JJ five_CD are_VBP intronless_JJ genes_NNS located_VBN on_IN chromosome_NN 2_CD ._SENT There_EX are_VBP two_CD mRNA_NN transcripts_NNS ,_, which_WDT arise_VBP in_IN a_DT ratio_NN of_IN 9:1_CD (_( shorter/longer_NN form_NN )_) ,_, where_WRB only_RB the_DT long_JJ transcript_NN is_VBZ regulated_VBN by_IN extracellular_JJ signals_NNS ._SENT It_PP has_VBZ been_VBN demonstrated_VBN that_IN malignant_JJ tissues_NNS with_IN accelerated_VBN cell_NN cycle_NN show_VBP higher_JJR levels_NNS of_IN ProTalpha_NP expression_NN than_IN normal_JJ or_CC surrounding_JJ healthy_JJ tissues_NNS ._SENT ProTalpha_NP was_VBD shown_VBN as_IN a_DT marker_NN for_IN breast_NN cancer_NN ,_, hepatocarcinoma_NN ,_, and_CC plasma_NN levels_NNS of_IN its_PP$ derivative_NN Talpha1_NN been_VBN proposed_VBN as_IN a_DT marker_NN for_IN the_DT prognosis_NN of_IN lung_NN cancer_NN ._SENT In_IN ligand_NN blotting_VBG assa_NN 